News

Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.

Collaboration aimed at discovery and development of small molecule inhibitors through to Phase I proof of mechanism in metabolic disorders therapeutic area.

Takeda Pharmaceutical and NsGene, Inc. have announced a research agreement to develop encapsulated cell therapies for the potential treatment of Parkinson’s disease.

ReNeuron Group, a leading UK-based stem cell therapy development company, is pleased to announce that it has been awarded a £2.1 million grant from Innovate UK to further advance its emerging exosome nanomedicine platform.

A University of York spin-out backed by the Royal Academy of Engineering’s Enterprise Hub, has been awarded a £300,000 grant from the UK’s innovation agency Innovate UK.

Aesica Pharmaceuticals has announced that it is actively recruiting for more skilled personnel at Queenborough ahead of the launch of its new development centre at the site.

Collaboration focuses on development of novel molecules using SMARTag technology to couple different therapeutic modalities.

Study reveals possible therapeutic strategy and a molecular mystery.

First step toward all-inclusive treatment.

Top scientists partner to research the progression and biology of RIA diseases.